Document is current

Any future updates will be listed below

Correction to: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

Crossref DOI link: https://doi.org/10.1186/s13569-019-0117-2

Published Online: 2019-05-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark